Kim Benstead

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial

Sarah Brown, Gary Middleton, Tim Maughan et al. · The Lancet Oncology · 2013 · 388 citations · Full text

Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial

Lisa Lowry, Paul Smith, Wendi Qian et al. · Radiotherapy and Oncology · 2011 · 381 citations

Local Control, Lymphoid Neoplasia, Surgical Oncology +9

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Fátima Cardoso, John M.S. Bartlett, Leen Slaets et al. · Annals of Oncology · 2017 · 381 citations · Full text

Eortc 10085/Tbcrc/big/nabcg, Breast Oncology, Medicine +7

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial

Helena Earl, Louise Hiller, Anne-Laure Vallier et al. · The Lancet · 2019 · 277 citations · Full text

The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients

Julia Scarisbrick, Pietro Quaglino, H. Miles Prince et al. · British Journal of Dermatology · 2018 · 216 citations · Full text